Hyperfine, Inc. splits its revenue into 2 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Product at $11.4 million, 84% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
|---|---|---|---|---|---|---|
| Revenue |
17
|
14
|
13
|
11
|
7
|
1
|
| Product |
14
+68.2%
share 85.7%
|
11
+9.1%
share 84.0%
|
10
+19.5%
share 81.1%
|
9
+66.7%
share 79.3%
|
5
+633.7%
share 77.0%
|
1
share 47.8%
|
| Services |
2
-0.4%
share 14.3%
|
2
-11.3%
share 16.0%
|
2
+6.7%
share 18.9%
|
2
+45.8%
share 20.7%
|
2
+100.8%
share 23.0%
|
1
share 52.2%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Electromedical & Electrotherapeutic Apparatus (SIC 3845)
- Listed as
- HYPR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Guilford, CT
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1833769
- Former names
- HealthCor Catalio Acquisition Corp. (until Dec 22, 2021)
Other Electromedical & Electrotherapeutic Apparatus companies
- Medtronic plc MDT
- LivaNova PLC LIVN
- Integer Holdings Corp ITGR
- Axogen, Inc. AXGN
- TransMedics Group, Inc. TMDX
- CONMED Corp CNMD
- Ceribell, Inc. CBLL
- InMode Ltd. INMD
All 31 Electromedical & Electrotherapeutic Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.